26825-1-AP

antibody from Proteintech Group

Targeting: CSTF2 CstF-64

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

26825-1-AP

Provider

Proteintech Group

Product name

CstF-64 antibody

Antibody type

Polyclonal

Description

CstF-64 antibody (Cat. #26825-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation.

Lin P, Chen W, Long Z, Yu J, Yang J, Xia Z, Wu Q, Min X, Tang J, Cui Y, Liu F, Wang C, Zheng J, Li W, Rich JN, Li L, Xie Q
Cell discovery 2024 Mar 19;10(1):32

---

A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma.

Huang Y, Xu J, Xie C, Liao Y, Lin R, Zeng Y, Yu F
Journal of hepatocellular carcinoma 2023;10:1639-1657

---

CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis.

Chen Z, Hao W, Tang J, Gao WQ, Xu H
Frontiers in oncology 2022;12:897804

---

Cleavage stimulating factor 64 depletion mitigates cardiac fibrosis through alternative polyadenylation.

Neupane R, Youker K, Yalamanchili HK, Cieslik KA, Karmouty-Quintana H, Guha A, Thandavarayan RA
Biochemical and biophysical research communications 2022 Mar 15;597:109-114

---

Chromodomain helicase DNA-binding domain 2 maintains spermatogonial self-renewal by promoting chromatin accessibility and mRNA stability.

Min Z, Xin H, Liu X, Wan J, Fan Z, Rao X, Fan J, Yang L, Li D
iScience 2022 Dec 22;25(12):105552

---

Suppression of premature transcription termination leads to reduced mRNA isoform diversity and neurodegeneration.

LaForce GR, Farr JS, Liu J, Akesson C, Gumus E, Pinkard O, Miranda HC, Johnson K, Sweet TJ, Ji P, Lin A, Coller J, Philippidou P, Wagner EJ, Schaffer AE
Neuron 2022 Apr 20;110(8):1340-1357.e7